Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1502671 | 0.98 | CES1 (0.32) | CES2CES1 | |
| SCHEMBL1567511 | 0.92 | CES1 (0.31) | CES2CES1 | |
| SCHEMBL87124 | 0.84 | — | — | |
| SCHEMBL14402711 | 0.82 | NAAA (0.30) | — | |
| Methacrylic Acid SCHEMBL27842089 | 0.82 | NAAA (0.30) | — | |
| Acetone SCHEMBL28639695 | 0.80 | MIF (0.36) | — | |
| Acetone SCHEMBL9650262 | 0.80 | MIF (0.36) | — | |
| Acetic Acid SCHEMBL28421734 | 0.78 | FFAR3 (0.35) | — | |
| SCHEMBL12697091 | 0.77 | CES1 (0.48) | CES2CES1 | |
| SCHEMBL28117761 | 0.76 | ALDH1A1 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100210812-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | SHOWA DENKO K.K. (JP) | 2010-08-19 | — | — | US | disclosed |
| US-20100087611-A1 | URETHANE COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT THEREOF | SHOWA DENKO K.K. (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-2172509-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | Showa Denko K.K. (JP) | 2010-04-07 | — | — | EP | disclosed |
| EP-2143739-A1 | URETHANE COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT OF THE COMPOSITION | Showa Denko K.K. (JP) | 2010-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087611-A1 | URETHANE COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT THEREOF | ITCH, GLI1, UNC119 | CES2 1369/4885CES1 3698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.